Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Neutropenia Biologic Drug Treatment industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Pfizer
Sanofi
Myelo Therapeutics GmbH
Baxter International
Kyowa Kirin
Teva Pharmaceutical Industries Ltd
Novartis
Partner Therapeutics
Dong-A ST CO Ltd
Cellerant Therapeutics
CVS Health
Amgen
Enzychem Lifesciences Corporation
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Filgrastim
Pegfilgrastim
Lenograstim
Lipegfilgrastim
Sargramostim
Application:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Neutropenia Biologic Drug Treatment Industry Overview
-
1.1.1 Neutropenia Biologic Drug Treatment Market Scope and Market Segments
-
1.1.2 Neutropenia Biologic Drug Treatment Industry Characteristics
-
1.1.3 Global and China Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Neutropenia Biologic Drug Treatment Production Value and Growth Rate (2017-2028)
-
1.2 Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Filgrastim
-
1.2.2 Pegfilgrastim
-
1.2.3 Lenograstim
-
1.2.4 Lipegfilgrastim
-
1.2.5 Sargramostim
-
1.3 Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Retail Pharmacies
-
1.3.2 Hospital Pharmacies
-
1.3.3 Online Pharmacies
-
1.4 Market Analysis by Region
-
1.4.1 North America Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Neutropenia Biologic Drug Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Neutropenia Biologic Drug Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Neutropenia Biologic Drug Treatment Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Neutropenia Biologic Drug Treatment Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Neutropenia Biologic Drug Treatment Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Neutropenia Biologic Drug Treatment Industry Porter's Five Forces Model Analysis
-
2.2.3 Neutropenia Biologic Drug Treatment Industry PEST Analysis
-
2.3 Neutropenia Biologic Drug Treatment Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Neutropenia Biologic Drug Treatment Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Neutropenia Biologic Drug Treatment Industry
Chapter 3 Global and China Neutropenia Biologic Drug Treatment Market, by Manufacturer
-
3.1 Global and China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Neutropenia Biologic Drug Treatment Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Neutropenia Biologic Drug Treatment Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Neutropenia Biologic Drug Treatment Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Neutropenia Biologic Drug Treatment Market Top 3 Players
Chapter 4 Global and China Neutropenia Biologic Drug Treatment Market, by Type (2017-2028)
-
4.1 Neutropenia Biologic Drug Treatment Market Trend, by Type
-
4.2 Global Neutropenia Biologic Drug Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Neutropenia Biologic Drug Treatment Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Neutropenia Biologic Drug Treatment Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Neutropenia Biologic Drug Treatment Price Trend, by Type (2017-2028)
-
4.3 China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Neutropenia Biologic Drug Treatment Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Neutropenia Biologic Drug Treatment Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Neutropenia Biologic Drug Treatment Price Trend, by Type (2017-2028)
Chapter 5 Global and China Neutropenia Biologic Drug Treatment Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Neutropenia Biologic Drug Treatment Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Neutropenia Biologic Drug Treatment Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Neutropenia Biologic Drug Treatment Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Neutropenia Biologic Drug Treatment Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Neutropenia Biologic Drug Treatment Market Analysis
-
7.1 North America Neutropenia Biologic Drug Treatment Market, by Type
-
7.2 North America Neutropenia Biologic Drug Treatment Market, by Application
-
7.3 North America Neutropenia Biologic Drug Treatment Market Analysis and Forecast, by Country
-
7.3.1 United States Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Neutropenia Biologic Drug Treatment Market Analysis
-
8.1 Europe Neutropenia Biologic Drug Treatment Market, by Type
-
8.2 Europe Neutropenia Biologic Drug Treatment Market, by Application
-
8.3 Europe Neutropenia Biologic Drug Treatment Market Analysis and Forecast, by Country
-
8.3.1 Germany Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Neutropenia Biologic Drug Treatment Market Analysis
-
9.1 APAC Neutropenia Biologic Drug Treatment Market, by Type
-
9.2 APAC Neutropenia Biologic Drug Treatment Market, by Application
-
9.3 APAC Neutropenia Biologic Drug Treatment Market Analysis and Forecast, by Country
-
9.3.1 China Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Market Analysis
-
10.1 Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Market, by Type
-
10.2 Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Market, by Application
-
10.3 Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Neutropenia Biologic Drug Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Neutropenia Biologic Drug Treatment Company Profiles
-
11.1 Pfizer
-
11.1.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Pfizer Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.1.3 Pfizer Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Sanofi
-
11.2.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Sanofi Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.2.3 Sanofi Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Myelo Therapeutics GmbH
-
11.3.1 Myelo Therapeutics GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.3.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Baxter International
-
11.4.1 Baxter International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Baxter International Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.4.3 Baxter International Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Kyowa Kirin
-
11.5.1 Kyowa Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.5.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Teva Pharmaceutical Industries Ltd
-
11.6.1 Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.6.3 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Novartis
-
11.7.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Novartis Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.7.3 Novartis Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Partner Therapeutics
-
11.8.1 Partner Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.8.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Dong-A ST CO Ltd
-
11.9.1 Dong-A ST CO Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.9.3 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Cellerant Therapeutics
-
11.10.1 Cellerant Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.10.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 CVS Health
-
11.11.1 CVS Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 CVS Health Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.11.3 CVS Health Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Amgen
-
11.12.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Amgen Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.12.3 Amgen Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Enzychem Lifesciences Corporation
-
11.13.1 Enzychem Lifesciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Profiles, Application and Specification
-
11.13.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Neutropenia Biologic Drug Treatment Industry Investment Prospect and Risk Assessment
-
12.1 Neutropenia Biologic Drug Treatment Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Neutropenia Biologic Drug Treatment Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Production Value and Growth Rate (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Production Value and Growth Rate (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Filgrastim (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Pegfilgrastim (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Lenograstim (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Lipegfilgrastim (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Sargramostim (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Retail Pharmacies (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Hospital Pharmacies (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Market Size and Growth Rate of Online Pharmacies (2017-2028)
-
Figure North America Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Neutropenia Biologic Drug Treatment Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Neutropenia Biologic Drug Treatment Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Neutropenia Biologic Drug Treatment Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Neutropenia Biologic Drug Treatment Market Share, by Manufacturer in 2021
-
Figure Global and China Neutropenia Biologic Drug Treatment Market Share, by Manufacturer in 2022
-
Table Global Neutropenia Biologic Drug Treatment Sales Volume, by Type (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Value, by Type (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Value Share, by Type (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Price Trend, by Type (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Volume, by Type (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Value, by Type (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Value Share, by Type (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Price Trend, by Type (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Volume, by Application (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Value, by Application (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Sales Value Share, by Application (2017-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Sales Value Share, by Application (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Volume, by Application (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Value, by Application (2017-2028)
-
Table China Neutropenia Biologic Drug Treatment Sales Value Share, by Application (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Value Share, by Application (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure North America Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Production, Import, Consumption and Export (2017-2022)
-
Table North America Neutropenia Biologic Drug Treatment Sales Volume, by Type (2017-2028)
-
Table North America Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Figure North America Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Table North America Neutropenia Biologic Drug Treatment Sales Volume, by Application (2017-2028)
-
Table North America Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure North America Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure United States Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure United States Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Canada Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Table Europe Neutropenia Biologic Drug Treatment Sales Volume, by Type (2017-2028)
-
Table Europe Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Figure Europe Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Table Europe Neutropenia Biologic Drug Treatment Sales Volume, by Application (2017-2028)
-
Table Europe Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Europe Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Germany Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure UK Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure UK Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure France Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure France Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Italy Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Spain Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Poland Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Russia Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Table APAC Neutropenia Biologic Drug Treatment Sales Volume, by Type (2017-2028)
-
Table APAC Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Figure APAC Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Table APAC Neutropenia Biologic Drug Treatment Sales Volume, by Application (2017-2028)
-
Table APAC Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure APAC Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure China Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Japan Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure India Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure India Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Neutropenia Biologic Drug Treatment Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Neutropenia Biologic Drug Treatment Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Neutropenia Biologic Drug Treatment Sales Value and Growth Rate (2017-2028)
-
Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Pfizer Product Profiles, Application and Specification
-
Table Pfizer Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Myelo Therapeutics GmbH Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Myelo Therapeutics GmbH Product Profiles, Application and Specification
-
Table Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Baxter International Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Baxter International Product Profiles, Application and Specification
-
Table Baxter International Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Kyowa Kirin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Kyowa Kirin Product Profiles, Application and Specification
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Pharmaceutical Industries Ltd Product Profiles, Application and Specification
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Partner Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Partner Therapeutics Product Profiles, Application and Specification
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Dong-A ST CO Ltd Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Dong-A ST CO Ltd Product Profiles, Application and Specification
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Cellerant Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Cellerant Therapeutics Product Profiles, Application and Specification
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CVS Health Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CVS Health Product Profiles, Application and Specification
-
Table CVS Health Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Enzychem Lifesciences Corporation Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Enzychem Lifesciences Corporation Product Profiles, Application and Specification
-
Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
